Hepatic TEAEs were defined using investigator selection of MedDRA preferred terms according to laboratory assessed terms (ALT increased, aspartate aminotransferase [AST] increased, blood bilirubin increased, transaminases increased) or non-laboratory assessed terms (hepatitis, immune-mediated hepatitis, autoimmune hepatitis, hepatic failure). This evidence concerns the gene GPT and Hepatic failure.